At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Varenicline for Smoking Cessation in Heavy Drinking Smokers
In Brief
A Phase 2 clinical trial evaluating Extended Varenicline Pretreatment and Short-term Varenicline Pretreatment for Nicotine Dependence and 2 related conditions. Completed, enrolled 30 participants.
Detailed Summary
The purpose of this study is to determine whether extended pretreatment with varenicline (Chantix) is more efficacious for smoking cessation than standard pretreatment, how well varenicline is tolerated in heavy drinking smokers, and whether varenicline reduces alcohol consumption.
Study Details
Timeline
Interventions
4 weeks varenicline (Chantix) titrated to 1 mg oral tablet twice per day before the smoking quit date followed by 4 weeks varenicline (Chantix) 1 mg oral tablet twice per day treatment.
3 weeks placebo + 1 week varenicline (Chantix)pretreatment + 4 weeks varenicline 1 mg oral tablet twice per day treatment following the smoking quit date.